Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?

Leggio, M

Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk? [electronic resource] - Diabetes & metabolism Jun 2018 - 217-225 p. digital

Publication Type: Journal Article; Review

1878-1780

10.1016/j.diabet.2017.11.002 doi


Aspirin--administration & dosage
Cardiovascular Diseases--prevention & control
Diabetes Complications--prevention & control
Fibrinolytic Agents--administration & dosage
Humans
Primary Prevention
Risk Factors